Megan G Hofmeister Selected Research

Hepatitis A (Hepatitis, Infectious)

1/2022	Prevalence and Types of Drugs Used Among Hepatitis A Patients During Outbreaks Associated with Person-to-Person Transmission, Kentucky, Michigan, and West Virginia, 2016-2019.
6/2021	Hepatitis A Virus Infections Among Men Who Have Sex with Men - Eight U.S. States, 2017-2018.
2/2021	Estimated Medicaid Costs Associated with Hepatitis A During an Outbreak - West Virginia, 2018-2019.
1/2021	Factors Associated With Hepatitis A Mortality During Person-to-Person Outbreaks: A Matched Case-Control Study-United States, 2016-2019.
1/2021	Hepatitis A Person-to-Person Outbreaks: Epidemiology, Morbidity Burden, and Factors Associated With Hospitalization-Multiple States, 2016-2019.
1/2020	Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.
1/2020	Homelessness and Hepatitis A-San Diego County, 2016-2018.
4/2019	Notes from the Field: Hepatitis A Outbreak Associated with Drug Use and Homelessness - West Virginia, 2018.
11/2018	Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel.
11/2018	Use of hepatitis A vaccine for post-exposure prophylaxis in individuals over 40 years of age: A systematic review of published studies and recommendations for vaccine use.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Megan G Hofmeister Research Topics

Disease

10	Hepatitis A (Hepatitis, Infectious) 01/2022 - 11/2018
7	Infections 06/2021 - 11/2018
2	Hepatitis 06/2022 - 11/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Hepatitis B 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	End Stage Liver Disease 01/2021
1	Virus Diseases (Viral Diseases) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Reinfection 01/2020

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 01/2021 - 11/2018
5	Pharmaceutical PreparationsIBA 01/2022 - 12/2018
2	Illicit Drugs (Recreational Drugs)IBA 06/2021 - 02/2021
2	Immunoglobulins (Immunoglobulin)IBA 11/2018 - 11/2018
1	antineoplaston A10 (A 10)IBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	AntibodiesIBA 01/2020
1	Hepatitis A AntibodiesIBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2019

Therapy/Procedure

1	Liver Transplantation 06/2022